| General Information of MET (ID: META00667) |
| Name |
Leucyl-Isoleucine
|
| Synonyms |
Click to Show/Hide Synonyms of This Metabolite
2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]-3-methylpentanoate; L-I dipeptide; L-Leucyl-L-isoleucine; LI dipeptide; Leu-ile; Leucine isoleucine dipeptide; Leucine-isoleucine dipeptide; Leucylisoleucine
|
| Source |
Endogenous;Endogenous
|
| Structure Type |
Amino acids, peptides, and analogues (Click to Show/Hide the Complete Structure Type Hierarchy)
Organic acids and derivatives
Carboxylic acids and derivatives
Amino acids, peptides, and analogues
|
| PubChem CID |
|
| HMDB ID |
|
| Formula |
C12H24N2O3
|
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=435718"></iframe>
|
 |
|
3D MOL
|
2D MOL
|
|
Click to Show/Hide the Molecular/Functional Data (External Links/Property/Function) of This Metabolite
|
| Physicochemical Properties |
Molecular Weight |
244.33 |
Topological Polar Surface Area |
92.4 |
| XlogP |
-1.6 |
Complexity |
267 |
| Heavy Atom Count |
17 |
Rotatable Bond Count |
7 |
| Hydrogen Bond Donor Count |
3 |
Hydrogen Bond Acceptor Count |
4 |
| Function |
Leucyl-Isoleucine is a dipeptide composed of leucine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an 'Expected' metabolite.
|
|
Regulatory Network
|
|
|
|
|
|
|
|
|
click to show the details of this protein
Induced Change
